Status:
RECRUITING
Study of Human Brain-Gut Axis and Gut Microbiome in Patients With Brain Lesions - Repository for Neuroscience Research
Lead Sponsor:
Mayo Clinic
Conditions:
Malignant Central Nervous System Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
This study explores how microorganisms in the gut can affect the growth and progression of brain tumors.
Detailed Description
PRIMARY OBJECTIVES: I. To establish a Mayo Clinic Florida Brain Tumor-Gut Axis Human Biorepository by sequential collection of fecal, urine, blood, saliva, and/or tissue samples and clinical patient ...
Eligibility Criteria
Inclusion
- All patients undergoing resection for a tumor of the central nervous system and associated controls are eligible to participate in this study.
Exclusion
- Excluded samples will be from patients younger than 18 years old. There are no exclusions due to race/sex.
Key Trial Info
Start Date :
February 28 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 13 2029
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06117930
Start Date
February 28 2024
End Date
December 13 2029
Last Update
September 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224-9980